Speciality: Pulmonary Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on Omalizumab in Severe Asthma: Indian perspective
Omalizumab, a monoclonal antibody targeting IgE, has emerged as an effective treatment for severe allergic asthma in India. It is particularly beneficial for patients whose asthma is inadequately controlled with standard therapies like inhaled corticosteroids and long-acting bronchodilators. By blocking IgE, which plays a central role in allergic reactions, omalizumab helps reduce the frequency and severity of asthma exacerbations, improving overall control of the condition.
In the Indian context, where pollution and environmental allergens are significant triggers for asthma, omalizumab offers a targeted approach to managing severe cases. Clinical experience in India has shown that patients on omalizumab experience fewer hospitalizations and a better quality of life. However, accessibility and cost remain barriers to widespread use, as biologic therapies can be expensive. Despite these challenges, omalizumab has become an important option for patients with severe allergic asthma who have not responded to conventional treatments, providing hope for improved outcomes in this population.
Therefore, get an overall knowledge of Omalizumab in Severe Asthma: Indian perspective
See More Webinars @ Hidoc Webinars
1.
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
5.
Microplastics can cause malignant changes in lung cells
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
5.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation